Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19
Condition(s):Severe Acute Respiratory Syndrome Coronavirus 2; COVID-19Last Updated:March 27, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Severe Acute Respiratory Syndrome Coronavirus 2; COVID-19Last Updated:March 27, 2023Completed
Condition(s):COVID-19 (SARS-CoV-2)Last Updated:February 8, 2021Completed
Condition(s):COVID; Sars-CoV2; Corona Virus Infection; Myositis; MyocarditisLast Updated:April 29, 2020Unknown status
Condition(s):SARS (Severe Acute Respiratory Syndrome); Covid19Last Updated:May 3, 2021Completed
Condition(s):SARSLast Updated:September 15, 2005Completed
Condition(s):COVID-19; SARS-CoV-2Last Updated:July 7, 2020Unknown status
Condition(s):Severe Acute Respiratory SyndromeLast Updated:March 1, 2024Completed
Condition(s):COVID-19Last Updated:January 24, 2022Completed
Condition(s):COVID-19Last Updated:November 8, 2021Withdrawn
Condition(s):Severe Acute Respiratory SyndromeLast Updated:March 23, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.